Benjamin Rapoport, MD, PhD Email Benjamin Rapoport
-
- Position
- ASSISTANT PROFESSOR | Neurosurgery
-
- Specialty
- Neurosurgery
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- Mount Sinai Queens
-
- Phone
- Mount Sinai Cerebrovascular Center 212-241-2763 212-241-2763
- 1000 10th Avenue 212-241-2763 212-241-2763
-
Mount Sinai Cerebrovascular Center
5 East 98th Street
7th Floor
New York, NY 10029
Phone: 212-241-2763212-241-2763
Ben Rapoport, MD, PhD, is an Assistant Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai. As a neurosurgeon in the Skull Base Surgery Center, he specializes in the diagnosis and minimally invasive surgical treatment of brain tumors and skull base pathologies.
Dr. Rapoport also serves as the Scientific Director of Mount Sinai BioDesign, a medical device incubator at Mount Sinai. The mission of Mount Sinai BioDesign is to help patients by creating technological solutions to medical problems in a way that generates jobs and high-value assets for Mount Sinai while educating a diversified generation of engineers and scientists. Dr. Rapoport’s mission as scientific director will be to catalyze technological innovation, translation, and commercialization within Mount Sinai. Mount Sinai BioDesign operates as a center of expertise in engineering and project management to enable Mount Sinai physicians and researchers to translate their ideas into commercially viable products and practical solutions to problems in healthcare.
Dr. Rapoport has extensive scientific training, receiving Master’s degrees in Physics from Harvard University and Mathematics from Oxford University, a PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology, and his medical degree from Harvard Medical School. He completed his neurosurgery residency, chief residency, and fellowship training in endovascular neurosurgery and endoscopic skull base surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He has a track record of technology translation in the areas of digital health, including serving as co-founder of Simbionics (acquired by Apple), and of neurotechnology, including serving as a cofounding member of Neuralink.
Dr. Rapoport has authored over 30 peer-reviewed scientific publications and obtained 10 patents, many of which are related to brain-computer interfaces and other innovations in medical technology.
Dr. Rapoport is committed to providing compassionate care to patients and their families while also delivering the most precise, technologically advanced, and minimally invasive treatments.
Clinical Focus
- Acoustic Neuroma Removal
- Acromegaly
- Adenomas
- Biopsy
- Brain Surgery
- Brain Tumors
- Brain, Spine Tumors
- Cerebrospinal Fluid Leak
- Craniopharyngioma
- Craniotomy
- Cushing's Syndrome
- Dural Arteriovenous Fistula (DAVF)
- Endovascular Embolization
- Hydrocephalus
- Intracerebral Hemorrhage (ICH)
- Meningioma
- Neuroendoscopy
- Pituitary Adenoma
- Pituitary Diseases
- Pituitary Macroadenomas
- Pituitary Tumor
- Skull Base Surgery
- Skull Base Tumor/Cancer
- Suprasellar Tumor
- Trigeminal Neuralgia
- Ventriculostomy
- Vestibular Schwannoma
Research Topics
Biomechanics/Bioengineering, Brain, Brain Imaging
Education
MD,PHD, Harvard Medical School
Residency, Neurological Surgery
New York Presbyterian Hospital Weill Cornell
Fellowship, Endovascular Neurosurgery
New York Presbyterian Weill Cornell
Fellowship, Neurological Surgery
New York Presbyterian Weill Cornell
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rapoport during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- Precision Neuroscience Corporation
Consulting:
- AngioWave Imaging LLC
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- AngioWave Imaging LLC
- Precision Neuroscience Corporation
Royalty Payments:
- AngioWave Imaging LLC
- Precision Neuroscience Corporation
- Rahnix
Scientific Advisory Board:
- Precision Neuroscience Corporation
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Precision Neuroscience Corporation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.